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Abstract
Objective:  To  assess  the  prevalence  of  Y-chromosome  sequences  and  gonadoblastoma  in
patients with  Turner  syndrome  (TS)  using  molecular  techniques.
Data  source:  A  literature  search  was  performed  in  Pubmed,  limiting  the  period  of  time  to
the years  2005--2014  and  using  the  descriptors:  TS  and  Y  sequences  (n=26),  and  TS  and  Y-
chromosome  material  (n=27).  The  inclusion  criteria  were:  articles  directly  related  to  the  subject
and published  in  English  or  Portuguese.  Articles  which  did  not  meet  these  criteria  and  review
articles were  excluded.  After  applying  these  criteria,  14  papers  were  left.
Data synthesis:  The  main  results  regarding  the  prevalence  of  Y-chromosome  sequences  in  TS
were: (1)  about  60%  of  the  studies  were  conducted  by  Brazilian  researchers;  (2)  the  prevalence
varied from  4.6  to  60%;  (3)  the  most  frequently  investigated  genes  were  SRY, DYZ3  and  TSPY;
(4) seven  studies  used  only  polymerase  chain  reaction,  while  in  the  remaining  seven  it  was
associated  with  FISH.  Nine  of  the  14  studies  reported  gonadectomy  and  gonadoblastoma.  The
highest prevalence  of  gonadoblastoma  (33%)  was  found  in  two  studies.  In  ﬁve  out  of  the  nine
papers evaluated  the  prevalence  of  gonadoblastoma  was  10--25%;  in  two  of  them  it  was  zero.
Conclusions:  According  to  these  data,  molecular  analysis  to  detect  Y-chromosome  sequencesregardless  of  their  karyotype.  In  patients  who  test  positive  for  thesein TS  patients  is  indicated,  
sequences,  gonadoblastoma  needs  to  be  investigated.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY  license  (https://creativecommons.org/licenses/by/4.0/).
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Prevalência  de  sequências  do  Y  e  de  gonadoblastoma  em  síndrome  de  Turner
Resumo
Objetivo:  Apresentar  a  prevalência  de  sequências  do  cromossomo  Y  por  técnicas  moleculares
e de  gonadoblastoma  em  pacientes  com  síndrome  de  Turner.
Fontes  de  dados:  Foi  feita  uma  pesquisa  bibliográﬁca  no  Pubmed,  com  limite  de  período  entre
2005 e  2014,  com  os  descritores  Turner  syndrome  and  Y  sequences  (n=26)  e  Turner  syndrome
and Y  chromosome  material  (n=27).  Os  critérios  de  inclusão  foram  artigos  que  tivessem  relac¸ão
direta com  o  tema  e  publicados  no  idioma  inglês  ou  português.  Foram  excluídos  aqueles  que
não cumpriram  esses  critérios  e  eram  do  tipo  revisão.  Após  aplicac¸ão  desses  critérios,  14  foram
selecionados.
Síntese dos  dados:  Os  principais  resultados  quanto  à  prevalência  de  sequências  do  cromossomo
Y em  síndrome  de  Turner  foram:  1  --  cerca  de  60%  dos  estudos  foram  feitos  por  pesquisadores
brasileiros;  2  --  a  frequência  variou  de  4,6  a  60%;  3  --  os  genes  SRY, DYZ3  e  TSPY  foram  os  mais
investigados;  4  --  a  técnica  de  PCR  foi  empregada  exclusivamente  em  sete  estudos  e  nos  sete
restantes,  associada  à  FISH.  Nove  dos  14  estudos  apresentaram  informac¸ões  sobre  gonadecto-
mia e  gonadoblastoma.  Dois  estudos  relataram  a  maior  prevalência  para  gonadoblastoma  (33%).
Cinco dos  nove  estudos  referiram  prevalência  de  10  a  25%  e  em  dois  esse  valor  foi  nulo.
Conclusões:  De  acordo  com  os  dados  apresentados,  é  indicada  a  pesquisa  molecular  para
sequências  do  cromossomo  Y  em  pacientes  com  ST,  independentemente  do  cariótipo.  Naquelas
com positividade  para  essas  sequências,  é  necessária  a  investigac¸ão  de  gonadoblastoma.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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sIntroduction
Turner  syndrome  (TS)  is  a  chromosomal  disorder  with  an
incidence  of  1:2500  girls;  its  etiology  is  associated  with
total  or  partial  X-chromosome  monosomy  and  the  diagno-
sis  is  made  by  karyotype  testing.1,2 A  retrospective  study  of
260  patients  with  TS  showed  that  the  improvement  in  chro-
mosomal  analysis  provided  a  change  in  the  proportion  of
observed  karyotype  types.3
Patients  with  TS  exhibit  have  short  stature  and  gonadal
dysgenesis  as  main  clinical  signs.  They  also  may  have  low
hairline  at  the  nape  of  the  neck,  strabismus,  ptosis,  high-
arched  palate,  micrognathia,  short  and/or  webbed  neck,
lymphedema  of  hands  and/or  feet,  metacarpal  and/or
metatarsal  shortening,  Madelung  deformity,  cubitus  val-
gus, genu  valgum,  scoliosis  and  multiple  pigmented  nevi,
cardiovascular  and  renal  disorders,  thyroid  disorders,  hear-
ing  impairment,  hypertension,  osteoporosis,  and  obesity.1,2
However,  this  syndrome  is  characterized  by  wide  pheno-
typic  variability,  from  patients  with  the  classic  phenotype
to  those  almost  indistinguishable  from  the  general  popula-
tion.
Women  with  TS  who  have  Y  chromosome  material  are
at  increased  risk  of  developing  gonadal  tumors,  such  as
gonadoblastoma  and  dysgerminoma.  Gonadoblastoma  is  a
benign  gonadal  tumor  with  a  high  potential  for  malignancy;
it  can  differentiate  into  invasive  dysgerminoma  in  60%  of
cases  and  also  in  other  forms  of  malignant  tumors.  About  90%
of  patients  with  gonadoblastoma  have  Y-chromosome  mate-
rial  in  their  genetic  makeup.  Therefore,  sequence  detection
of  Y-chromosome  by  cytogenetic  and/or  molecular  tech-
niques  in  patients  with  TS  is  critical.  In  positive  cases,
prophylactic  removal  of  gonads  has  been  indicated.4 Two
R
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iecently  published  retrospective  studies  showed  Y  chromo-
ome  material  frequencies  in  TS  by  classical  cytogenetics  of
.6%  (4/61)5 and  7.6%  (12/158).6 In  one  such  study,  33%  of
atients  (4/12)  had  gonadoblastoma  and  in  two  patients  it
rogressed  to  disgerminona  or  teratoma.6 In  another  study
ith  11  patients  with  sexual  differentiation  disorders,  7
ad  Turner  phenotype  and  mosaic  karyotype  Y  in  peripheral
lood.7 All  patients  with  TS  underwent  gonadectomy,  and
istopathological  ﬁndings  revealed  that  four  of  them  (57.1%)
ad  gonadoblastoma,  and  in  two  cases  it  was  associated  with
ysgerminoma.7 Regarding  the  classical  cytogenetic  analy-
is  by  GTG  banding,  peripheral  blood  lymphocytes  are  the
aterial  of  choice  because  it  is  easy  to  harvest  this  tis-
ue,  and  the  analysis  is  usually  performed  in  30  metaphases,
hich  allows  detection  of  10%  of  mosaicism.8 The  advantage
f  molecular  methods  is  that  it  require  no  cell  culture  and
nly  a  small  sample  for  analysis  and  are  more  sensitive  to
etect  low  mosacismo,  frequent  in  TS.8
Thus,  the  aim  of  this  review  is  to  present  the  prevalence
f  Y  chromosome  sequences  by  molecular  techniques  and
onadoblastoma  in  patients  with  TS.
ethod
 literature  search  was  performed  on  Pubmed,  on
0/24/2014,  with  time  limit  between  2005  and  2014.  Fig.  1
hows  the  ﬂowchart  of  this  electronic  search.esults
able  1  shows  the  frequency  of  Y  chromosome  sequences,
dentiﬁed  by  molecular  techniques,  of  the  14  selected
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Eletronic search
(Pubmed)
Descriptors:
Turner syndrome and Y sequences
n=26 (“search 1”)
Descriptors:
Turner syndrome and Y chromosome material
n=27 (“search 2”)
Total: 53 articles
7 articles: Searches 1 and 2
5 articles: Search 1 
2 articles: Search 2
Articles included from the review
n=14
Articles excluded from the review
n=39
• Unrelated to the subject
• Publication in another language
• Review articles
• Directly related to the subject (selection by
  title and/or abstract analysis) 
• Publication in English or Portuguese
Inclusion reasons Exclusion reasons
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iFigure  1  Representation  of  the  
tudies.  Table  2  shows  the  karyotype  of  these  patients.  The
requency  of  gonadoblastoma  in  TS  patients  with  positive
mpliﬁcation  for  Y-chromosome  is  summarized  in  Table  3,
ith  information  on  gonadectomy  and  gonadoblastoma  in  TS
i
i
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Table  1  Frequency  of  Y-chromosome  sequences  identiﬁed  by  mo
Reference  Method(s)  and  Y-chromosome  sequen
and/or  probe  used
Bianco  et  al.9 PCR:  SRY/DYZ3  
Bianco et  al.10 PCR:  SRY/DYZ3  
Bianco et  al.11 PCR:  SRY/DYZ3/TSPY  
Bianco et  al.12 PCR:  SRY/TSPY  
Barros et  al.3 PCR  and  PCR  nested:  SRY/TSPY/DYZ
Barros et  al.13 PCR  and  PCR  nested:  SRY/TSPY/DYZ
DXZ1/DYZ3
Araujo et  al.14 PCR:  SRY/ZFY/DYZ1/PABY/DYS1/DYZ
Bispo et  al.15 FISH:  CEP  X/CEP  Y;  PCR  multiplex:
SRY/TSPY/AMGY/DAZ
Mazzanti et  al.16 PCR:  SRY/DYZ3;  FISH:  CEP  18  SA/X  S
Semerci et  al.17 PCR:  PABY/SRY/DYS14/AMGY/DYZ3/
DYS280/DYS218/DYS224/DYS209/DY
DYS1/YRRM/DYZ1
Sallai et  al.18 RT-PCR:  SRY/DDX3Y/HSFY1/TSPY;  FI
whole  chromosome  painting  Y/wcp
Cortés-Gutiérrez  et  al.19 PCR:  SRY; FISH:  CEP-Y  
Freriks et  al.20 FISH:  CEP  X/CEP  Y/SRY;  PCR:  Yp  (SRY
(sY84/sY86/sY127/sY134/sY254/sY2
RT-PCR:  SRY/DSY14
Knauer-Fischer  et  al.21 FISH:  Ycen-1089/1090;  PCR  Multiple
(GBY:  TSPY/SRY),  Yq11  (AZFa/AZFb/
PY, patients with Y sequence; PCR, polymerase chain reaction; SRY, se
Y; FISH, ﬂuorescence in situ hybridization; RT-PCR real-time PCR; DDX
transcription factor, Y-linked; AZF, azoospermia factor; CEP X, X-speci
gonadoblastoma Y gene; TSPY, testis-speciﬁc protein Y-encoded or testod  and  electronic  search  results.
n  9 of  14  studies.  The  results  of  ﬁve  studies3,14,15,17,21 are  not
ncluded  in  Table  3  for  the  following  reasons:  (1)  two  stud-
es  had  no  information  on  gonadectomy  and  gonadoblastoma
n  the  text3,21; (2)  in  two  studies  patients  were  scheduled
lecular  techniques  in  patients  with  Turner  syndrome.
ce(s) n/origin  PY  Frequency
20/Brazil  7  35.0%
5/Brazil  3  60.0%
87/Brazil  16  18.5%
104/Brazil  17  16.3%
3  96/Brazil  10  10.4%
3;  FISH: 101/Brazil  16  15.8%
3  42/Brazil  2  4.8%
74/Brazil  5  6.8%
G/Y  SO  171/Itly  14  8.2%
DYS273/
S231/
40/Turkey  2  5.0%
SH: 130/Hungary  9  (RT-PCR)  6.9%
6 (FISH)  4.6%
32/Mexico  3  9.4%
)  and  Yq
55);
63/Holland  5  7.9%
x:  Yp11
AZFc)
60/Germany  7  11.7%
x-determining region on the Y chromosome or sex related region
3Y, DEAD/H box polypeptide, Y-chromosome; HSFY1, heat-shock
ﬁc centromeric probe; CEP Y, Y-speciﬁc centromeric probe; GBY,
is speciﬁc protein Y.
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Table  2  Karyotypes  determined  by  conventional  cytogenetics  (GTG)  in  patients  with  Y-chromosome  sequences  identiﬁed  by
molecular techniques.
Reference  Karyotypes
Bianco  et  al.9 45,X:  n=7
Bianco  et  al.10 45,X/46,X,+mar:  n=2;  45,X/45,X,add(15)(p11):  n=1
Bianco et  al.11 45,X:  n=12;  45,X/46,X,+mar:  n=2;  45,X/45,X,add(15)(p11):  n=1;  45,X/46,X,r(?):  n=1
Bianco et  al.12 45,X:  n=12;  45,X/46,X,+mar:  n=2;  45,X/45,X,add(15)(p11):  n=1;  45,X/46,X,r(?):  n=1;
45,X/47,XXX:  n=1
Barros  et  al.3 45,X/46,X,+mar:  n=5;  45,X:  n=3;  45,X/46,X,r(?):  n=2
Barros et  al.13 45,X:  n=3;  45,X/46,XY:  n=5;  45,X/46,X,+mar:  n=5;  45,X/46,X,r(?):  n=2;  45,X/47,XYY:  n=1
Araujo et  al.14 45,X:  n=2
Bispo et  al.15 45,X/46,XY:  n=2;  45,X:  n=1;  45,X/46,XY:  n=1;  46,X,i(Xq):  n=1
Mazzanti et  al.16 45,X/46,XY:  n=6;  45,X:  n=2;  45,X/46,X,idic(Y):  n=3;  45,X/46,X,+mar:  n=2;
45,X/46,XY/46,X,idic(Y):  n=1
Semerci  et  al.17 45,X:  n=2
Sallai et  al.18 45,X:  n=3;  45,X/46,XY:  n=3;  45,X/46,X,+mar:  n=2;  45,X/46,X,del(Xq):  n=1
Cortés-Gutiérrez  et  al.19 45,X/46,X,+mar:  n=1;  45,X/46,XY:  n=1;  45,X:  n=1
Freriks et  al.20 45,X:  n=5
21 11.2)
21):  
Y
O
f
p
t
a
oKnauer-Fischer  et  al. 45,X:  n=2;  45,X/46,X,idicY(q
46,X,der(X)t(X;Y)(p22.3;q11.
for  clinical  follow-up17 or  monitoring  by  a  multidisciplinary
team  of  biologist,  psychologist,  geneticist,  endocrinolo-
gist,  and  gynecologist14;  and  (3)  in  one  study  prophylactic
gonadectomy  was  offered  to  all  patients  with  Y  sequences,
however,  the  same  patients  opted  for  regular  monitoring  by
ultrasound  and  CT.15
DiscussionThe  present  literature  review  study  showed  the  preva-
lence  of  Y-chromosome  sequences  and  the  risk  of  developing
gonadoblastoma  in  TS  patients.
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Table  3  Frequency  of  gonadoblastoma  in  patients  with  Turner  sy
Reference  PY/P  total  PG/PY  P
Bianco  et  al.9 7/20  4/7  (57.1)  1
Bianco et  al.10 3/5  3/3  (100)  0
Bianco et  al.11 16/87  11/16  (68.7)  2
Bianco  et  al.12 17/104  12/17  (70.6)  2
Barros  et  al.13 16/101  16/16  (100)  3
Mazzanti et  al.16 14/171  12/14  (85.7)  4
Sallai  et  al.18 9/130  9/9  (100)  1
Cortés-Gutiérrez  et  al.19 3/32  3/3  (100)  1
Freriks et  al.20 5/63  4/5  (80)  0
PY/P total, patients with Y sequence in relation to the total number of
with Y sequence; PG operated, gonadoblastoma patients undergoing s
R, right; E, left; GBB, bilateral gonadoblastoma; GBM, gonadoblastoma
a Age at diagnosis.
b Age at gonadectomy.:  n=2;  46,X,i(X)(q10):  n=1;  46,X,del(X)(q12  ou  q13.1):  n=1;
n=1
-chromosome  sequences
f  the  14  studies  included  in  this  review,  60%  were  per-
ormed  by  Brazilian  investigators.3,9--15 Four  have  been
ublished  by  the  same  group  and  the  two  studies  repor-
ing  a  higher  prevalence  of  Y-chromosome  sequences9--12
nalyzed  samples  from  different  tissues  (peripheral  blood,
ral  mucosa  cells,  and  hair  root).9,10 One  study  evaluated
90  patients  with  TS  and  karyotype  45,X and  the  other  5
atients  with  chromosomal  abnormalities,  such  as  chromo-
ome  marker,  additional  material,  or  ring  chromosome.10
hree  studies9--11 showed  that  all  investigated  patients  had
ndrome  and  Y-chromosome  sequences.
G  operated  %  With
gonadoblastoma
PG  age  (years)
 25.0  16
 0  --
 18.2  16  and  19a
 16.7  16  and  19a
 18.8  15.9b (OCT4+:  GL);
18.2b (OCT4+:
GR);
17.7b (OCT4+:  GR
and  GL)
 33.3  7.64  and  2.8:  GBBb
15.9  and  11.6:
GBMb
 11.1  5.5b
 33.3  10
 0  --
 patients; PG/PY, gonadoblastoma patients compared to patients
urgery; OCT4, octamer-binding transcription factor 4; G, gonad;
 monolateral.
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t18  
mpliﬁcation  for  SRY  gene  and  only  a  few  for  DYZ3  and
SPY.  This  data  shows  that  the  SRY  gene  should  be  especially
nvestigated  in  patients  with  TS.9--11 In  a  study  published  in
010,  Bianco  et  al.12 also  evaluated  gene  expression  (SRY,
SPY, SF1,  WT1, DAX1, OCT4, GATA4, FOG2, STRA8) in  right
nd  left  gonads  of  six  patients  undergoing  gonadectomy
nd  found  no  difference  in  the  expression  of  these  genes
n  this  tissue  both  in  patients  and  controls,  except  in  one
ase  with  high  expression  of  genes  SRY,  TSPY,  and  OCT4
n  both  gonads  [karyotype:45,X/45,X,add(15)(p11)].  These
ine  investigated  genes  are  involved  in  sex  determination,
ifferentiation,  and  gonadal  tumorigenesis.12 In  this  study,12
ll  patients  showed  SRY  gene  ampliﬁcation,  which  highlight
he  ﬁndings  previously  publicados.9--11 The  studies  pre-
ented  above  used  exclusively  the  polymerase  chain  reaction
PCR)  technique  for  the  investigation  of  Y-chromosome
equences  in  TS9--12 and  reported  frequencies  ranging  from
6.3  to  60%.
Two  studies  performed  by  another  group  of  investiga-
ors  also  used  PCR  and  PCR  in  it.3,13 One  of  them  assessed
-chromosome  sequences  in  96  TS  patients  a  total  of
60.3 This  research  was  indicated  only  in  cases  of:  (a)
5,X  karyotype  and  negative  X-chromatin;  (b)  presence
f  marker  chromosomes  in  karyotype,  i.e.,  chromosome
ragments  of  unknown  origin;  and  (c)  impossibility  of  cyto-
enetic  identiﬁcation  of  ring  chromosome  origin.  Thus,  96
atients  met  these  criteria  and  of  these  10  showed  posi-
ive  ampliﬁcation  for  the  investigated  genes.  In  this  same
tudy,  six  cases  of  intact  Y-chromosome  had  previously
een  identiﬁed  by  classical  cytogenetics  (45,X/46,XY:  n=5
nd  45,X/47,XYY:  n=1).  In  a  subsequent  study,  these  same
uthors  evaluated  101  of  260  TS  patients  by  PCR  and,
hen  positive,  they  used  the  ﬂuorescence  in  situ  hybridiza-
ion  (FISH)  technique.13 The  101  cases  analyzed  by  PCR  for
-chromosome  sequences  showed  45,  X  karyotype  and  nega-
ive  Barr  corpuscle  (n=73),  marker  chromosome  (n=25),  and
ing  chromosome  (n=3).
Two  other  studies  reported  the  lower  Y-chromosome  fre-
uency  values  among  studies  performed  in  Brazil.14,15 In  four
S  patients,  the  detection  of  Y-chromosome  sequences  was
dentiﬁed  only  by  PCR  [karyotypes:  45,X  and  46,X,i(Xq)].14,15
hus,  the  inclusion  of  PCR  technique  in  TS  routine  investiga-
ion  would  be  indicated.14 It  is  noteworthy  that  six  Brazilian
tudies  have  used  only  the  PCR  technique  for  the  inves-
igation  of  Y-chromosome  sequences.  Advantages  of  this
echnique  include:  (1)  quick  execution;  (2)  low  cost;  (3)
imultaneous  processing  of  multiple  samples;  (4)  applicabil-
ty  in  screening  of  a  large  number  of  patients;  and  (5)  high
ensitivity  for  detection  of  mosaicism.  The  use  of  PCR  to
nvestigate  14  Y-chromosome  sequences  identiﬁed  a  preva-
ence  of  5%,17 value  similar  to  that  reported  by  a  study
nalyzing  only  six  sequences.14
FISH  and  PCR  techniques  were  concurrently  used  in
everal  studies.15,16,18--21 One  study  published  in  2005  iden-
iﬁed  a  frequency  of  about  6%  by  classical  cytogenetics
10/171)  and  8%  by  molecular  analysis  (14/171).16 In  another
tudy,19 GTG  banding  revealed  three  positive  cases:  kary-
types  45,X/46,X,mar;  45,X/46,XY,  and  45,X.  FISH  analysis
f  lymphocytes  revealed:  (1)  that  the  marker  chromo-
ome  was  Y;  (2)  conﬁrmed  the  Y-chromosome  previously
dentiﬁed  by  classical  cytogenetics;  and  (3)  did  not  iden-
ify  Y-chromosome  material,  respectively.  FISH  analysis  of
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onadal  tissue  showed  that  Y-chromosome  was  present  in  57,
6  and  26%  of  cells,  respectively.  Investigation  by  PCR/SRY
n  lymphocytes  and  gonads  was  positive  in  all  three  cases.
he  case  considered  Y-negative  in  lymphocytes  by  GTG  and
ISH  (45,X)  was  positive  for  SRY  by  PCR/lymphocytes.  There-
ore,  the  authors  suggested:  (1)  the  use  of  PCR,  in  addition
o  conventional  cytogenetic  analysis,  to  rule  out  the  pos-
ibility  of  hidden  Y-chromosome  mosaicism;  and  (2)  the
se  of  FISH  technique  only  after  a  positive  result  for  PCR
ecause  it  is  expensive  and  laborious.19 In  addition  to  FISH,
eal-time  PCR  (RT-PCR)  was  also  used.18,20 The  ﬁrst  study18
dentiﬁed  Y-chromosome  mosaicism  by  conventional  cyto-
enetic  analysis  in  three  of  the  130  patients  investigated
karyotypes:  45,X/46,XY  n=3).  Two  patients  have  mosaicism
round  the  Y-chromosome,  while  the  other  patient  had  only
art  of  the  Y-chromosome.  By  RT-PCR,  nine  patients  were
ositive  for  Y.  Of  the  four  Y-chromosome  speciﬁc  probes
sed  in  the  RT-PCR  technique,  two  (SRY  and  TSPY1) are
n  the  Y-chromosome  short  arm  (Yp)  and  two  (DDX3Y  and
SFY1)  on  the  long  arm  (Yq).  Six  patients  had  ampliﬁca-
ion  to  the  four  sequences,  three  to  two  (SRY  and  TSPY1)
r  three  (SRY, TSPY1, and  DDX3Y) sequences;  that  is,  three
atients  had  no  complications  of  HSFY1  gene  and  one  had
oss  of  DDX3Y  region,  which  suggests  Yq  deletion.  FISH
nalysis  conﬁrmed  positive  for  Y  in  six  cases.  Thus,  the
requency  of  Y-chromosome  sequences  was  2.3,  4.6,  and
.9%  by  GTG  bands,  RT-PCR,  and  FISH  techniques,  respec-
ively.  In  the  2013  study,20 with  162  TS  patients,  75  had
 45,X  karyotype  and  of  these  63  have  agreed  to  undergo
dditional  molecular  investigations.  Y  sequences  were  iden-
iﬁed  by  FISH  in  ﬁve  patients  on  oral  cell  samples  but
ot  in  peripheral  blood  lymphocytes  by  PCR.  RT-PCR  anal-
sis  revealed  the  presence  of  SRY  and  DYS14  in  two  of
hem.20 In  another  study,  the  combined  use  of  PCR  and
ISH  allowed  the  identiﬁcation  of  a  frequency  of  approxi-
ately  12%  of  Y-chromosome  sequences  in  TS.  Of  the  seven
atients  with  Y-sequences,21 four  did  not  show  it  in  the  kary-
type.
In  short,  in  the  present  study  the  frequency  of  Y-
hromosome  sequences  in  TS  patients  ranged  from  4.6  to
0%.  According  to  the  literature,  the  prevalence  is  0--61%.19
his  difference  may  be  due  to  the  following  factors:
election  criteria  of  patients,  sample  size,  methodology,
nd  Y-chromosome  markers  used.  When  the  analyzed  tissue
as  peripheral  blood  alone,  the  prevalence  of  Y  sequences
anged  from  4.6  to  18.5%.11,21 However,  in  studies  where
ore  than  one  tissue  evaluated,  the  prevalence  was
reater.9,10 SRY, DYZ3, and  TSPY  genes  were  the  most
idely  investigated.  SRY  gene  is  located  in  the  short  arm
f  Y-chromosome  (Yp11.3)  and  DYZ3  gene  in  the  pericen-
romeric  region  at  Yp12.  Both  genes  play  a  role  in  sex
etermination  and  chromosomal  stability,  respectively.22
SPY  (testis-speciﬁc  protein  Y  encoded),  located  in  the
onadoblastoma  region  of  the  Y-chromosome  (GBY)  at
p11.2,  is  involved  in  the  development  of  gonadoblastoma
nd  its  expression  was  detected  in  this  tissue  and  testis.23--25
egarding  technique,  seven  studies3,9--14,17 used  PCR  alone
o  investigate  Y-chromosome  sequences  in  TS  and  in  the
emaining  seven  studies  FISH  was  also  used.13,15,16,18--21 An
ntriguing  ﬁnding  was  reported  by  one  of  these  studies,
hich  found  Y-negative  sequences  in  all  56  cases,  including
he  ﬁve  positive  cases  by  FISH/buccal  cells.20 This  result
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contradicts  those  published  in  the  literature  that  recom-
mend  the  use  of  PCR  in  the  investigation  of  Y-chromosome
sequences  in  TS.  The  authors  attribute  this  low  sensitivity
to  the  difﬁculty  in  detecting  mosaicism  below  10%.20
Chromosomal  mosaicism  is  deﬁned  as  the  presence  of
two  or  more  distinct  cell  lines  within  the  same  individual
resulting  from  post-zygotic  nondisjunction.  When  it  occurs
in  already  differentiated  cells,  mosaicism  may  be  conﬁned
to  one  or  a  few  tissues.26 In  this  context,  investigation  of
Y-chromosome  sequences  in  tissues  of  different  embryonic
origins  is  advised,  such  as  cells  of  the  oral  mucosa,  which
can  easily  be  harvested  by  non-invasive  procedures.
To  our  knowledge,  there  is  only  one  systematic  review
focusing  on  clinical  and  genetic  characteristics  of  TS,
mosaicism,  Y-chromosome,  and  risk  of  gonadal  tumor.8 Data
presented  in  this  study  show:  (1)  that  the  detection  of  Y-
chromosome  sequences  in  TS,  regardless  of  the  karyotype,
is  necessary  to  prevent  the  development  of  gonadoblastoma;
and  (2)  PCR  technique  should  be  employed  due  to  its  high
sensitivity,  low  cost,  and  easy  to  perform.
After  TS  conﬁrmation  by  cytogenetics,  the  inclusion  of
the  PCR  technique  is  suggested  as  a  complement  for  detec-
tion  of  Y-chromosome  sequences  in  these  patients.  This
molecular  technique  is  more  sensitive  and  can  detect  the
presence  of  Y-chromosome  material.
Gonadoblastoma
Gonadoblastoma,  often  observed  in  the  second  decade  of
life,  is  a  benign  gonadal  tumor  with  a  high  potential  for
malignant  transformation.4 It  has  a  good  prognosis  and
may  differentiate  into  a  germ  cell  tumor,  such  as  dysger-
minomas,  and  less  frequently  into  teratomas,  embryonal
carcinoma,  yolk  sac  tumor,  and  choriocarcinoma.13 This
tumor  is  present  mainly  in  women  with  gonadal  dysgenesis,
and  approximately  95%  of  them  have  Y-chromosome  mate-
rial  in  their  genomes.  Therefore,  the  detection  of  these
sequences  by  cytogenetic  and/or  molecular  techniques  has
been  encouraged  to  guide  the  prophylactic  indication  for
surgical  removal  of  gonads  in  this  group  of  patients,  as  gen-
erally  they  are  not  metastatic  tumors,  and  there  is  the
possibility  of  cure  with  their  removal.4 Women  with  TS
have  gonadal  dysgenesis  and  therefore  the  detection  of  the
Y-chromosome  sequences  in  these  patients  is  of  extreme
clinical  importance.
The  highest  prevalence  for  gonadoblastoma  in  this  review
was  33%16,19 and  is  in  line  with  other  studies.6,27 This  percent-
age  was  identiﬁed  in  a  recent  survey,  and  four  patients  with
ST  had  the  karyotype  45,X/46,XY.6 Two  of  them  had  a  dys-
germinoma  (age  at  surgery:  11.25  years)  and  a  teratoma  (15
years).  In  the  two  patients  with  gonadoblastoma  alone,  age
at  surgery  was  1.5  and  11.7  years.6 Another  study  published
recently  reported  35.3%  incidence  of  gonadoblastoma.28
Twenty  patients  with  TS  had  Y-chromosome  sequences  from
a  total  of  217  and  17  of  them  underwent  gonadectomy.28 An
even  higher  frequency  was  reported  by  Alvarez-Nava  et  al.29
who  investigated  52  patients  and  detected  four  with  Y-
chromosome  sequences  (7.7%),  all  underwent  gonadectomy
and  two  had  gonadoblastoma  (50%).  Five  studies  reported
incidence  of  10--25%.9,11--13,18 Previous  studies  have  reported
frequencies  of  7--10%30 and  16.7%.31 These  ﬁndings  show  that
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he  frequency  of  gonadoblastoma  is  variable  and  may  reﬂect
n  early  investigation.
In studies  performed  by  Bianco  et  al.,9--12 results  obtained
ere:  (1)  one  45,X  patient  with  bilateral  gonadoblas-
oma  positive  SRY  gene  ampliﬁcation  for  the  three  tissues
nalyzed9;  (2)  two  patients  with  bilateral  gonadoblas-
oma  [45,X:  SRY+  and  45,X/46,X,r(?):  SRY+DYZ3+]11; (3)  two
atients  with  bilateral  gonadoblastoma  [45,X:  SRY+ and
5,X/46,X,r(?):  SRY+].12 Although  there  was  no  patient  iden-
iﬁed  with  gonadoblastoma,  histopathological  study  of  the
onads  of  one  patient  revealed  stromal  cell  hyperplasia  and
uteoma.10 Subsequent  studies  also  showed  patients  with
hese  histopathological  ﬁndings.11,12
Another  gene  associated  with  gonadoblastoma  is  OCT4
octamer-binding  transcription  factor  4),12,13 also  known  as
CT3  or  POU5FI.  This  gene  is  considered  to  be  a  tumor
arker  of  germ  cells,  such  as  gonadoblastoma,  dysger-
inoma,  seminoma,  and  others,  and  its  expression  was
etected  by  immunohistochemistry  in  100%  of  cases  of
onadoblastoma.32 The  study  published  in  2010  showed
igh  expression  of  the  SRY,  TSPY, and  OCT4  genes  in  both
onads  of  a  patient  with  positive  PCR  (SRY+ and  TSPY+).12
nother  study  showed  that  immunohistochemical  analy-
is  for  OCT4  was  positive  in  three  cases  (karyotypes:  45,
/46,XY:  n=2  and  45,X/46,X,+mar:  n=1),  a  suggesting  result
f  germ  cell  tumor  (gonadoblastoma  or  carcinoma  in  situ).13
n  this  study,  the  16  cases  of  Y  sequences  underwent  bilat-
ral  gonadectomy,  and  the  left  and  right  gonads  were
ssessed  by  conventional  staining  with  hematoxylin  and
osin  (H&E)  and  immunohistochemical  staining  for  OCT4.
onadal  neoplasia  was  not  detected  in  any  of  32  gonads
valuated  by  H&E;  however,  four  gonads  (12%)  of  three
atients  (19%)  were  positive  for  OCT4, suggesting  the  exis-
ence  of  germ  cell  tumors.13 For  this  reason,  the  authors
ecommend  a  speciﬁc  histopathological  study  in  gonads,
uch  as  OCT4  immunohistochemistry,  to  assess  the  real  risk
f  gonadal  tumors  in  patients  with  TS  and  Y-chromosome
equences.12,13
Regarding  the  studies  that  reported  a  higher  prevalence
f  gonadoblastoma,  one  of  them  reported  two  patients
ith  monolateral  gonadoblastoma  (karyotype:  45,X  and
5,X/46,X,+mar)  and  two  with  bilateral  gonadoblastoma
karyotype:  45,X/46,XY)16 and  the  other  reported  a  patient
5,X/46,XY  with  gonadoblastoma.19 In  the  study  published
n  2010,  prophylactic  surgery  was  performed  in  all  nine
atients  with  Y-chromosome  material  before  age  of  20  and
ne  of  them,  a  girl  of  5-year  old,  the  youngest  patient
n  the  study,  had  bilateral  gonadoblastoma  without  clini-
al  signs.18 This  patient  had  a  45,X/46,XY  karyotype  (GTG),
cpY+93 (FISH),  and  was  positive  for  all  Y-speciﬁc  sequences
SRY,  TSPY1, DDX3Y, and  HSFY1).  Ovarian  tissue  histology
evealed  no  gonadoblastoma  in  four  of  the  patients  under-
oing  gonadectomy.20
A  recent  histopathological  study  reported  gonadal  tumors
n  6  out  of  11  patients  (56%),  including  4  out  of  7  (57%)
ith  TS.7 Two  patients  with  TS  had  gonadoblastoma  in
he  right  and  left  gonads  [karyotypes  and  age  at  gonadec-
omy,  respectively:  45,X/45,X,t  (15;  Y)(p11.2;  q11.2)  and years  and  11  months;  45,X/46,XY  and  10  years  and  3
onths].  Gonadoblastoma  associated  with  dysgerminoma
as  seen  in  only  one  gonad  (right,  in  a  patient;  and  left,  in
ther)  and  in  two  other  patients  (karyotype  45,X/46,XY  and
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6,X,+der(15)/46,XY  and  ages:  11  years  and  6  months  and
5  years  and  4  months,  respectively).  The  youngest  patient
ith  TS  submitted  to  gonadectomy  was  2 years  old.7
According  to  data  presented,  it  can  be  concluded
hat  molecular  investigation  is  indicated  for  Y-chromosome
equences  in  TS  patients,  regardless  of  the  karyotype,  as
 complement  to  the  cytogenetic  diagnosis.  PCR  is  the
echnique  suggested  because  it  is  inexpensive,  sensitive,
apid,  and  enable  the  tracking  of  various  sequences  of  Y-
hromosome  simultaneously.  It  would  also  be  appropriate  for
nalysis  of  a  second  tissue,  in  addition  to  peripheral  blood.
n  those  patients  with  Y-positive  sequences,  gonadoblastoma
nvestigation  is  required.
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